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susceptibility to myocardial ischemia/reperfusion
injury via activation of sensory TRPV1 and β1
adrenoreceptors
Sarah Robertson1,2, Ashleigh L Thomson1, Rod Carter1, Holly R Stott1, Catherine A Shaw1, Patrick W F Hadoke1,
David E Newby1, Mark R Miller1 and Gillian A Gray1*Abstract
Background: Clinical studies have now confirmed the link between short-term exposure to elevated levels of air
pollution and increased cardiovascular mortality, but the mechanisms are complex and not completely elucidated.
The present study was designed to investigate the hypothesis that activation of pulmonary sensory receptors and
the sympathetic nervous system underlies the influence of pulmonary exposure to diesel exhaust particulate on
blood pressure, and on the myocardial response to ischemia and reperfusion.
Methods & Results: 6 h after intratracheal instillation of diesel exhaust particulate (0.5 mg), myocardial ischemia and
reperfusion was performed in anesthetised rats. Blood pressure, duration of ventricular arrhythmia, arrhythmia-
associated death, tissue edema and reperfusion injury were all increased by diesel exhaust particulate exposure.
Reperfusion injury was also increased in buffer perfused hearts isolated from rats instilled in vivo, excluding an
effect dependent on continuous neurohumoral activation or systemic inflammatory mediators. Myocardial
oxidant radical production, tissue apoptosis and necrosis were increased prior to ischemia, in the absence of
recruited inflammatory cells. Intratracheal application of an antagonist of the vanilloid receptor TRPV1 (AMG
9810, 30 mg/kg) prevented enhancement of systolic blood pressure and arrhythmia in vivo, as well as basal and
reperfusion-induced myocardial injury ex vivo. Systemic β1 adrenoreceptor antagonism with metoprolol (10 mg/
kg) also blocked enhancement of myocardial oxidative stress and reperfusion injury.
Conclusions: Pulmonary diesel exhaust particulate increases blood pressure and has a profound adverse effect on the
myocardium, resulting in tissue damage, but also increases vulnerability to ischemia-associated arrhythmia and reperfusion
injury. These effects are mediated through activation of pulmonary TRPV1, the sympathetic nervous system and locally
generated oxidative stress.
Keywords: (3-10) air pollution, Ischemia/reperfusion injury, Sympathetic nervous system, Vanilloid receptorBackground and objectives
Exposure to air pollution is associated with increased car-
diovascular mortality and morbidity [1]. These associations
are strongest for the particulate matter (PM) in air pollu-
tion, and exist even when exposure is only acute (reviewed
in [2]). Ultrafine particles (particles with a diameter of less* Correspondence: gillian.gray@ed.ac.uk
1BHF/ University Centre for Cardiovascular Science, Queens Medical Research
Institute, University of Edinburgh, Edinburgh, Scotland, UK
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article, unless otherwise stated.than 100 nanometers, UFP or PM0.1) are of specific con-
cern because their small size engenders them with a large
reactive surface area and allows them to penetrate deep into
the respiratory tract [3]. Exhaust from diesel engines is es-
pecially rich in ultrafine particles and therefore may con-
tribute greatly to the health effects of PM in urban
environments [4].
The proposed link between air pollution and increased
incidence of fatal and non-fatal myocardial infarction (MI)
has recently been confirmed in a systematic review andtral Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly credited. The Creative Commons Public
mons.org/publicdomain/zero/1.0/) applies to the data made available in this
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ing clinical and experimental evidence for detrimental ef-
fects of diesel exhaust and other PM on blood pressure,
coronary vascular function, atherosclerotic plaque develop-
ment and stability, and on thrombosis and clot resolution,
all factors that will increase the likelihood of MI [6]. How-
ever, epidemiological evidence suggests that there is more
to increased cardiovascular death than enhanced risk of
MI. In the Women’s Health Initiative [7] and the Nurses’
Health Study [8], the impact of PM exposure on cardiovas-
cular mortality was much larger than for incidence of MI
events. The evidence suggests a biological mechanism for
PM that also involves effects on the myocardium itself.
Such a mechanism may account for the increased incidence
of ventricular arrhythmias reported in patients with im-
plantable defibrillators following exposure to pollution or
PM [9]. Experimental studies support a damaging effect of
PM on the myocardium, as exposure in vivo causes impair-
ment in cardiac function and arrhythmia [10-12]. In mice,
both concentrated ambient particles [13] and particulate
matter [14], increase susceptibility to ischemia/reperfusion
(I/R) injury.
The mechanism by which pulmonary exposure to par-
ticulate matter is associated with myocardial injury and
susceptibility to I/R is currently unclear. Systemic inflam-
mation, occurring secondary to pulmonary inflammation, is
a potential candidate for transmission of PM effects from
the lung to the heart. However, evidence supporting the oc-
currence of systemic inflammation varies in the literature
and is more compelling for chronic, rather then acute PM
exposure [1,15]. Alternatively, exposure of the lung to PM
might influence distant organs via neurohumoral activation
[12]. Exposure to PM is associated with elevation of blood
pressure [16,17] and there is evidence that this is mediated
by activation of the sympathetic nervous system [18]. Auto-
nomic outflow from the central nervous system (CNS) can
be adjusted by sensory feedback from the lung [19], and
several studies have demonstrated the ability of PM to acti-
vate these sensory pathways [10,11,20,21].
The hypothesis investigated in the present study is that
activation of sensory transient receptor vanilloid receptors
and of adrenergic receptors link pulmonary exposure to
diesel exhaust particulate (DEP) with hemodynamic per-
turbation, myocardial injury and the response to myocardial
ischemia and reperfusion.
Results
Pulmonary exposure to DEP increases blood pressure,
ischemic arrhythmia, infarct size and mortality
Systolic, diastolic and mean arterial pressures, as well as
rate-pressure product (RPP), were all elevated in rats 6 h
after DEP compared to saline or no instillation, but there
was no significant change in heart rate. (Figure 1a and
b, Additional file 1: Table S1). No arrhythmias wererecorded during the baseline period before induction of
I/R in any of the experimental groups.
Induction of ischemia by coronary artery ligation resulted
in a typical transient drop in systolic blood pressure that
returned to pre-ischemic levels within 10-15 min, this was
accompanied by an increase in RPP (Additional file 1: Table
S2). Arrhythmias were detected within 5 min of ischemia
induction and typically lasted for 8 ± 1 min (Figure 1c).
Prior instillation of DEP increased total arrhythmia
duration to 33 ± 5 min (P < 0.01), while saline instilla-
tion had no effect (Figure 1c). Arrhythmias were ac-
companied by death within 15 min of the onset of
ischemia in 60% of the rats that had received DEP.
Sudden cardiac death did not occur in either non-
instilled or saline-instilled animals.
Infarct size was assessed after 2 h of reperfusion.
While Evans Blue exclusion could be used to delineate
area at risk (AAR) in saline-instilled animals, this was
not the case in animals that had received DEP. In these
animals only, Evans Blue consistently leaked into the
AAR at the end of reperfusion. An accompanying in-
crease in heart weight (Figure 1d, inset) in DEP instilled
animals following ischemia and reperfusion suggests
that enhanced capillary permeability is likely to underlie
leakage of Evans Blue into the ischemic zone. In all sub-
sequent in vivo studies Evans Blue was not therefore
administered and infarct size was calculated as % left
ventricular (LV) mass. Infarct size in non-instilled ani-
mals averaged 13 ± 1% of total LV mass (Figure 1d), and
this was not changed by saline instillation. In contrast,
infarct size in DEP-instilled rats was increased threefold
to 35 ± 2% of LV mass (P < 0.001).Neutrophil priming and recruitment do not account for
effects of pulmonary DEP on the heart
White blood cell (WBC) concentration was increased in
blood collected 6 h after DEP instillation (P < 0.05, See
Additional file 1: Methods and Additional file 1: Figure
S1a), whereas red blood cells (RBC) and platelet concen-
trations did not differ between groups (data not shown).
Elevation of WBC was not associated with any change
in the plasma concentration of the neutrophil chemo-
attractant CXCL8 (See Additional file 1: “Methods” and
Additional file 1: Figure S1b). Flow cytometric analysis
of whole blood, to assess whether systemic neutrophil
priming contributed to DEP-enhanced myocardial in-
jury, did not reveal any difference in either basal or
fMLP-induced neutrophil activation (CD11b expres-
sion) between groups (Additional file 1: Figure S1c).
Histological evaluation of sections from hearts col-
lected 6 h after DEP instillation showed no evidence of
inflammatory cell recruitment to the heart prior to in-
duction of ischemia (data not shown).
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Figure 1 Pulmonary exposure to DEP increases basal blood pressure, oxygen demand, ischemic arrhythmia and reperfusion injury in vivo.
Mean arterial blood pressure (MABP, a), rate pressure product (RPP, b) and the duration of ischemic arrhythmia (c, with inset showing typical arrhythmia)
were measured in anesthetised rats 6 h after pulmonary instillation of diesel exhaust particulate (DEP, 0.5 mg, filled black columns) or 0.9% saline (saline,
0.5 ml, open columns) and in control rats that received no instillation (non-instilled, filled grey column). Hearts from DEP instilled rats had increased infarct
size (d), expressed as a percentage of left ventricular (LV) mass) and were heavier at the end of reperfusion (d, inset). Results are expressed as mean ± SEM
(n = 6 per group) ***P < 0.001 saline versus DEP; one-way ANOVA followed by Bonferroni post-hoc test.
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heart is perfused ex vivo
To determine the dependence of increased I/R injury on
concurrent inflammatory cell recruitment or neurohu-
moral influences in vivo, hearts were isolated from rats
6 h after DEP or saline instillation, or from non-instilled
rats, and buffer-perfused ex vivo in Langendorff mode.
Neither baseline coronary perfusion pressure (CPP),
nor AAR after induction of ischemia, was different be-
tween groups (Additional file 1: Table S3). Leakage of
Evans Blue into the AAR did not occur in hearts from
DEP instilled animals, in contrast to in vivo studies,
allowing reperfusion injury to be calculated at % AAR.
In agreement with in vivo observations, infarct size fol-
lowing ischemia and reperfusion ex vivo was increased
in hearts from DEP-instilled rats relative to hearts iso-
lated from saline-instilled or non-instilled rats (P < 0.001;
Figure 2a).
Oxidant stress, determined by electron paramagnetic
resonance (EPR) of the heart perfusate before induction
of ischemia and reperfusion, was higher in hearts from
DEP-instilled rats (P < 0.01; Figure 2b & c). All hearts
showed a small burst of oxidant stress on reperfusion
but this did not differ between treatment groups (data
not shown). In separate hearts, fixed 6 h after DEPinstillation and prior to I/R, detection of TUNEL-labelled
apoptotic cells was increased relative to hearts from non-
instilled or saline instilled hearts (P < 0.01; Figure 3a & b),
while assessment of tetrazolium chloride staining showed a
corresponding loss in myocardial cardiac cell viability
(P < 0.01, Figure 3c).Systemic β1 adrenoreceptor blockade prevents DEP-induced
cardiac injury and promotion of reperfusion injury ex vivo
The role of the sympathetic nervous system in mediating
the effects of DEP was investigated by administration of
the β1 adrenoreceptor selective antagonist, metoprolol
(10 mg/kg i.p.), at the time of DEP instillation in vivo. In
hearts isolated and buffer-perfused 6 h later, neither the
baseline perfusion pressure nor the AAR after ischemia
was influenced by prior in vivo β1 adrenoreceptor block-
ade (Additional file 1: Table S4). However, an influence
of DEP on ex vivo reperfusion injury was absent in rats
that had received metoprolol at the time of DEP instilla-
tion in vivo (Figure 4a). Hearts were not protected when
metoprolol was added only to the perfusate ex vivo
(Figure 4a, inset), confirming that protection occurs as
a result of prevention of β1 adrenoreceptor activation
in vivo. In vivo treatment with metoprolol was also
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Figure 2 Infarct size and oxidant stress generation was increased in hearts isolated from DEP instilled rats and perfused ex vivo. Myocardial
infarct size (a, expressed as percentage of area at risk; AAR) and (b, c) oxygen free radicals (via quantification of CP˙ spin adducts by electron paramagnetic
resonance; EPR) in coronary perfusate of hearts from non-instilled rats (non-instilled, grey column) and hearts isolated 6 h after instillation of saline (saline,
0.5 ml, open columns) or DEP (0.5 mg, black column). Results are expressed as mean ± SEM (n = 4-6) **P < 0.01, ***P < 0.001 saline versus DEP; one-way
ANOVA followed by Bonferroni post-hoc test.
Robertson et al. Particle and Fibre Toxicology 2014, 11:12 Page 4 of 10
http://www.particleandfibretoxicology.com/content/11/1/12effective in reducing DEP-associated oxygen free rad-
ical generation (P < 0.01, Figure 4b), apoptotic cell
death (Figure 4c), and the corresponding reduction in
cardiomyocyte viability prior to I/R (Figure 4d).Pulmonary administration of a TRPV1 channel antagonist
in vivo prevents DEP-induced enhancement of myocardial
injury ex vivo
The role of pulmonary TRPV1 receptors in mediating the
influence of DEP on the myocardium was investigated by
co-instillation in vivo of the TRPV1 antagonist AMG 9810
(30 mg/kg) with DEP into the lung. Enhancement of ex vivo
reperfusion injury associated with DEP in buffer-perfused
hearts was prevented by AMG 9810 co-instillation in vivo
(Figure 5a). Treatment had no influence on either baseline
CPP or AAR (Additional file 1: Table S4). Furthermore,
AMG 9810 had no influence on injury in hearts from DEP-
instilled rats when given only ex vivo in the Langendorff
perfusate, confirming that the effects of this drug interven-
tion were mediated prevention of TRPV1 activation in vivo
(Figure 5a inset). Increased apoptosis (Figure 5b) and re-
duced cardiac viability (Figure 5c) associated with heartsfrom DEP-instilled rats were also prevented by AMG 9810
treatment in vivo.Pulmonary TRPV1 channel blockade prevents the
DEP-induced enhancement of blood pressure and
arrhythmia in vivo
To investigate whether TRPV1 blockade might also be
a means of preventing the in vivo effects of DEP, AMG
9810 (30 mg/kg) was co-instilled with DEP into the
lung 6 h prior to anesthesia and induction of I/R. AMG
9810 co-treatment prevented the increase in blood
pressure associated with DEP administration (SBP:
131 ± 8 mmHg, n = 4 after DEP compared to 101 ±
9 mmHg, n = 4 after saline instillation, P < 0.05, and
112 ± 10 mmHg, n = 5 with DEP after AMG9810). Co-
administration of AMG also tended to reduce the dur-
ation of ischemic arrhythmias in DEP-instilled animals,
from 17 ± 12 min to 8 ± 1 min, comparable with dur-
ation in saline instilled rats (6 ± 2 mmHg). AMG 9810
itself had no significant effect on blood pressure (110 ±
7 mmHg, n = 4) or ischemic arrhythmia duration (8 ±
1 min) in saline-instilled animals. These results suggest
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Figure 4 β1 adrenoceptor blockade in vivo prevented the effects of intratracheal DEP on infarct size, myocardial oxidant stress, apoptosis, cell
viability ex vivo. Infarct size was reduced in hearts isolated from DEP instilled (filled columns) compared to controls (open columns) rats when metoprolol
was co-administered in vivo (10 mg/kg, i.p., hatched columns a), but not when metoprolol was present only in the perfusate ex vivo (10 μM, hatched
column, (a) inset panel). The DEP-induced changes in oxygen-derived free radicals in the coronary perfusate, (electron paramagnetic resonance; EPR, b),
number of apoptotic cells (TUNEL staining, c), and loss of cardiomyocyte viability (TTC staining, d) in the left ventricle (LV) were prevented when metoprolol
(10 mg/kg, i.p., hatched columns) was administered in vivo at the time of instillation. Results are expressed as mean ± SEM (n = 6), **P < 0.01, ***P < 0.001
versus saline; ##P < 0.01, ###P < 0.001 versus DEP without metoprolol; two-way ANOVA followed by Bonferroni post-hoc test.
Non-instilled Saline DEP0
50
100
150
**
M
yo
ca
rd
ia
l v
ia
bi
lit
y
(%
 of
 LV
)
c
a
25µm
25µm
Non-instilled Saline
0.0
0.1
0.2
0.3
0.4
0.5
ap
op
to
tic
 c
el
ls
/2
 m
m
2
***
DEP
saline
DEP
b
Figure 3 Intratracheal DEP instillation increased apoptotic cell death and reduced cardiomyocyte viability. (a) Representative images of
left ventricle from rats 6 h after instillation of DEP (0.5 mg, lower panel) or saline (0.5 ml, upper panel) showing blue staining of TUNEL-positive
apoptotic cells. DEP instillations (black columns, b) increased the number of apoptotic cells in the heart and (c) decreased the area of viable
myocardium (% of left ventricle (LV)), compared to hearts from non-instilled (grey columns) and saline instilled (open columns) rats. Results are
expressed as mean ± SEM (n = 3-4) **P < 0.01, **P < 0.001, saline versus DEP; one-way ANOVA followed by Bonferroni post-hoc test.
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Figure 5 Pulmonary TRPV1 blockade in vivo prevented the effects
of intratracheal DEP on infarct size, myocardial apoptosis and cell
viability ex vivo. Co-instillation of the TRPV1 antagonist AMG 9810
(hatched columns, 30 mg/kg) with DEP in vivo prevented the increase in
myocardial infarct size (expressed as a percentage of area at risk;
AAR) induced by DEP (0.5 mg, black column, a). AMG9810 had no
effect on infarct size when present only in the perfusate ex vivo
(1 μM, hatched column, (a) inset panel). When co-administered
in vivo AMG 9810 also prevented the greater levels of apoptosis
(TUNEL staining, b) and loss of cell viability (TTC staining, c)
associated with pulmonary DEP exposure. Results are expressed
as mean ± SEM (n = 3-5), **P < 0.01 versus saline; ##P < 0.01 versus
DEP without AMG 9810; two-way ANOVA followed by Bonferroni
post-hoc test.
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pressure and arrythmogenesis associated with DEP
instillation.Discussion
The link between environmental air pollution and car-
diovascular mortality is now clear, but the mechanisms
are complex, varying, and not completely elucidated
[1,22]. The current study demonstrates that, within a
few hours of pulmonary exposure to DEP, there is a sig-
nificant increase in blood pressure, damage to the myo-
cardium and an increase in sensitivity to I/R induced
myocardial injury and arrhythmia. Hearts isolated from
animals exposed to DEP in vivo produce more oxidant
stress and retain increased vulnerability to subsequent
injury induced ex vivo. Outcomes from pharmacological
intervention studies support a role for pulmonary sen-
sory TRPV1 receptors and also β1 adrenoreceptors, in
mediating these effects.
Elevation of blood pressure has been widely reported
in clinical and experimental studies involving both
acute and chronic exposure to environmental pollutants
[22,23]. Diesel exhaust, and other sources of urban
air pollution, represent complex mixes of gases, semi-
volatile liquids and particulates. Multiple epidemiological
studies have demonstrated that the associations between
air pollution and cardiovascular disease are strongest
for the particulate components of air pollution. In the
present study, to avoid the confounding influences of
gaseous co-pollutants, DEP was administered to the
lungs by intra-tracheal instillation, a highly reliable and
reproducible method for producing excellent dispersion
of particles throughout the lobes of rodent lungs and
across the alveoli [17,24,25] This intervention resulted in
increased blood pressure within 6 h of exposure. The
dose of 0.5 mg, while high relative to doses achieved in
inhalation studies, is nevertheless within the range used
in other studies of particle exposure. Previous work in
our laboratory has shown that while this dose of DEP in-
creased blood pressure, it did not result in impaired in
endothelial function or in systemic inflammation [17],
suggesting that this instillation model does not result in
acute severe toxicity, despite the relatively high level of
exposure. Several neurohumoral mechanisms have been
proposed to account for blood pressure increases in re-
sponse to environmental pollution in experimental and
clinical studies, including the release of endothelin, acti-
vation of the renin-angiotensin-aldosterone system and
sympathetic activation [16,18]. Nonetheless, the mecha-
nisms linking pulmonary exposure to pollutants with
neurohumoral activation remain poorly defined. In vitro
and in vivo studies have demonstrated that sensory re-
ceptors, including the transient receptor potential vanil-
loid type 1 (TRPV1), as well as TRPA1, can be activated
by the cationic components of PM [20,21]. In the lung,
activation of sensory receptors initiates a feedback re-
sponse via the dorsal root, jugular and sometimes nod-
ose ganglia to the CNS, with resultant effects on
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ciated elevation of systolic blood pressure was abrogated
when the selective TRPV1 receptor antagonist, AMG
9810, was administered into the lung at the time of DEP
instillation, supporting a key role for sensory receptor
activation in mediating the hypertensive effects of DEP.
Sympathetic nerves and TRP currents have previously been
implicated in mediating cardiac electrophysiological in-
stability associated with inhaled PM [10,11,20,21]. Findings
here show that ischemia-associated arrhythmia was pro-
longed in rats that had been exposed to DEP and the sever-
ity of arrhythmia frequently led to death. This was also
suppressed by pulmonary administration of the TRPV1 an-
tagonist, lending further support to a key role for sensory
nerve activation in mediating the effects of pulmonary DEP
[10,11,20], and showing that activation of TRP is not
dependent on the route of PM delivery. The data generated
here hint at a link between sensory receptor and regulation
of the sympathetic nervous system. However, further
studies are required to fully understand the nature of this
association through direct recording of sensory and sympa-
thetic nerve fibre activation and of ion fluxes. Drugs that
selectively block parasympathetic activation e.g. atropine,
might also be included. This would reveal whether a true
sensory reflex is evoked following exposure of the lung to
particulate matter or whether other mechanisms, such as
alteration of baroreflex sensitivity, are involved.
The incidence of fatal and non-fatal MI is increased
clinically following exposure to air pollution [5], and this
can occur within 6 h after exposure to fine particulate
matter [27]. While some experimental studies have shown
increased myocardial reperfusion injury 24 h after instilla-
tion of ultrafine particulate [13], or exposure to gaseous
components of air pollution [28], the more acute effects
and the underlying mechanisms remain largely unexplored.
The primary aim of this study was to investigate whether
susceptibility of the heart to ischemic injury was modified
following acute exposure of the lung to diesel particulate
and to gain some insight into mechanism. The study used a
well-evaluated and characterised model of ischemia and re-
perfusion injury [17,29]. The data clearly shows that rats
are rendered more vulnerable to in vivo myocardial ische-
mia and reperfusion within 6 h of DEP exposure with an
increase in infarct size and an apparent increase in vascular
permeability. In the intact animal, hemodynamic status or
modification of neutrophil activation or recruitment to the
injured myocardium could potentially underlie potentiation
of myocardial injury. An increase in rate pressure product
following instillation of DEP indicates that an increase in
the energy demand of the heart, likely resulting from the
increased blood pressure, might have contributed to in-
creased injury associated with ischemia in vivo. Neutrophil
numbers were also increased in blood after DEP expos-
ure, although there was no concomitant increase in theconcentration of the neutrophil chemoattractant mole-
cules IL-8, or in IL-6 [30]. However, increased suscep-
tibility to injury was reproduced ex vivo in hearts
removed after in vivo DEP exposure, excluding an
essential role for in vivo hemodynamic influences or
blood borne inflammatory cells. This is supported by
flow cytometric evaluation of granulocyte status that
failed to reveal any evidence for neutrophil priming
or activation following DEP exposure. These findings
support the notion that modification of myocardial
homeostasis following pulmonary exposure to compo-
nents of air pollution might underlie the increased in-
cidence of non-MI related cardiac death reported in
epidemiological studies [7,8].
To address this issue further, hearts were investigated
6 h after exposure to DEP and prior to induction of
MI. Increased oxidative stress generation was detected
through direct measurement of reactive oxygen species
in heart perfusate by EPR. This was associated with
apoptosis and loss of cardiomyocyte viability. Local oxi-
dant stress generation by the heart could be key in sensi-
tizing the heart to injury, by inducing damage directly as
shown, but also potentially by depleting the heart’s anti-
oxidant capacity, leaving it more vulnerable to oxidant
molecules generated during subsequent reperfusion [28].
Indeed, administration of antioxidant has previously
been shown to prevent spontaneous myocardial arrhyth-
mias induced by inhalation of concentrated ambient par-
ticles in rats [12]. Neutrophils are an important source
of oxidant stress following reperfusion. It is very likely
that oxidant stress associated with recruited neutrophils
contributed to the apparent increase in vascular leak
that followed in vivo, but not ex vivo I/R, in hearts from
DEP exposed rats. However, histology confirmed that no
neutrophils were present in hearts prior to induction of
I/R. Neutrophils are not therefore likely to be respon-
sible for the increase in baseline oxidant stress in hearts
from DEP exposed rats. Other potential sources of the
ROS in the myocardium include mitochondria, xanthine
oxidase and nicotinamide adenine dinucleotide phos-
phate (NADPH) oxidase and several of these sources of
free radicals are known to be upregulated following ex-
posure to environmental particulates [30]. NADPH oxi-
dases are of particular interest since these enzymes are
widely distributed within the heart and they can be acti-
vated via β1 adrenoreceptor stimulation, either directly
[31], or secondary to activation of the renin-angiotensin
aldosterone system [32]. In the present study, increased
baseline oxidant stress generation, apoptosis and loss of
cardiomyocyte viability were prevented when metopro-
lol, a β1 adrenoreceptor antagonist with no direct anti-
oxidant effects, was administered in vivo at the same
time as DEP. Furthermore, this treatment also prevented
sensitization of the isolated perfused heart to subsequent
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above, autonomic activation following DEP exposure may
occur secondary to activation of the pulmonary transient
receptor potential cation (TRP) channels, resulting in in-
creased blood pressure. TRP channel activation has also
been implicated in mediating increased myocardial oxidant
stress in rats exposed to inhaled diesel exhaust, or CAPs, al-
though the specific components responsible have not been
identified. [10,11]. To investigate their role in mediating
apoptosis and sensitization to I/R in hearts from DEP ex-
posed rats, the TRPV1 antagonist AMG 9810 was instilled
into the lung in vivo with DEP 6 h prior to heart isolation.
Blockade of TRPV1 completely prevented not only loss of
cardiomyocyte viability prior to induction of ischemia but
also the potentiation by DEP of reperfusion injury in iso-
lated hearts. These observations support a key role for TRP
activation in mediating the subsequent effects of intratra-
cheal DEP at sites distant from the lung. While the TRP an-
tagonist was administered into the pulmonary circulation,
it is not possible to completely exclude blockade of recep-
tors in the systemic circulation, that might also contribute
to outcome. Ex vivo perfusion studies however suggest that
a direct effect on cardiac TRPV1 does not account for the
outcomes reported. In vitro experiments have shown that
DEP interacts with TRPA1, in addition to TRPV1 [20,21].
Further experiments targeting blockade of these receptors
are merited to further test their in vivo role.
The clinical relevance of these findings remains to be
tested. There is growing clinical evidence that agrees
with our observation of acute cardiovascular responses
to particulate components of air pollution [2]. For ex-
ample, changes in systolic blood pressure were found
to occur within 30-60 minutes of acute exposure [23].
There are currently no controlled clinical studies of β
adrenoreceptor antagonists or sensory neuron block-
ade in relation to pollution and cardiovascular out-
comes. Interestingly though, de Hartog et al. [33]
have demonstrated that associations between heart
rate variability and exposure to traffic derived particu-
late matter are strongest in patients not taking β adre-
noreceptor antagonists.
Study limitations
(1) The study depends on the use of instillation for
introduction of diesel particulate to the lungs and
the dose selected, while non-toxic and similar to
many other studies, is high relative to normal levels
of exposure.
(2) While inhalation can also cause changes in blood
pressure and electrical stability, there is a possibility
that the responses reported here following
instillation may not be triggered by real-world
inhalation, and that humans may not respond inthe same manner as the experimental animals
used in this study.
Conclusions
The data presented here demonstrate that within 6 h of
a single exposure of the lung to DEP, by instillation,
blood pressure is elevated and the myocardium is locally
generating oxidant stress, resulting in injury, consistent
with previous observations following inhalation of diesel
exhaust [11,34-37]. Furthermore, the heart is rendered
significantly more vulnerable to subsequent ischemic
arrhythmia and to reperfusion-associated injury. While
systemic inflammation and inflammatory cell recruit-
ment appear not to be required, activation of sensory
TRPV1 receptors, and of β1 adrenoreceptors are key to
mediating these events.
Materials and methods
Animals
Adult male Wistar rats (200-250 g; Charles River, Margate,
UK) were housed under controlled environmental condi-
tions (21 ± 2°C; 12 h light/dark cycle) with access to tap
water and standard laboratory rat chow ad-libitum. All rats
were allowed to acclimatize to the environment for at least
one week before experimental procedures were initiated.
All experiments were performed according to the guide-
lines of the Animals (Scientific Procedures) Act 1986 (U.K.
Home Office) and the National Institutes of Health (NIH
Publication No. 85-23, revised 1996) and were approved by
the ethical review committee for animal research at the
University of Edinburgh.
Intratracheal instillation of DEP
DEP (SRM-2975; National Institute of Standards and
Technology, Gaithersburg, USA) was suspended in 0.9%
sterile saline at a stock concentration of 1 mg/mL and
sonicated for 5 min (70% power; 5 Hz) in an ice bath
using a probe-type sonicator (US70; Philip Harris Scien-
tific, Lichfield, U.K) to minimise particle aggregation.
DEP (0.5 mg) or an equivalent volume (0.5 mL) of
0.9% saline was administered by intra-tracheal instilla-
tion under light anaesthesia as previously described
[38,39]. The dose used is comparable to previous studies
[17,38,40,41]. An additional group of non-instilled rats
was used to confirm that saline instillation itself did not
contribute to myocardial injury.
Ischemia/Reperfusion in vivo and ex vivo
6 h after instillation, rats were anesthetized (sodium pento-
barbital (60 mg.kg-1 i.p.)) and prepared for hemodynamic
assessment and for induction of ischemia and reperfusion
(I/R) in vivo, or hearts were rapidly isolated and
perfused in Langendorff mode ex vivo (for details, see
Additional file 1: Methods). Infarct size was determined
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tails, see Additional file 1: Methods). In ex vivo perfused
hearts, oxygen free radical generation was assessed in per-
fusate by spin-label electron paramagnetic resonance
[29,42] using the spin trap 1-hydroxy-3-carboxy-pyrolidine
(CP-H, 10-3 M) (for details, see Additional file 1: Methods).
Drug treatment studies
Rats were randomly assigned to receive the β1-adrenore-
ceptor antagonist metoprolol (10 mg/kg i.p.)[43] or saline
immediately before instillation, or the TRPV1 antagonist,
AMG 9810 ((2E)-N-(2,3- Dihydro-1, 4-benzodioxin-6-yl)-
3-[4-(1, 1- dimethylethyl)phenyl]-2-propenamide, 30 mg/
kg) [44] intra-tracheally, dispersed in either DEP or in
saline. In additional groups, ex vivo hearts underwent
I/R while perfused with Tyrode’s containing metoprolol
(10 μM) or AMG 9810 (1 μM), to control for any direct
influence of the drugs on reperfusion injury.
Drugs and reagents
Unless otherwise stated all pharmacological agents were
obtained from Sigma Aldrich (Dorset, U.K.) and all basic
salts were obtained from VWR (Leicestershire, U.K.). All
drugs were dissolved in sterile 0.9% saline unless other-
wise stated.
Statistical analysis
Data are expressed as the mean ± standard error of the
mean (SEM). Statistical comparisons were performed by
one-way analysis of variance (ANOVA) followed by Bonfer-
roni post-hoc tests (baseline hemodynamic, infarct size and
EPR data) or two-way ANOVA using the Bonferroni post-
hoc test (drug intervention studies), unless otherwise stated.
Statistical analyses were performed using GraphPad Prism
software (V5.0; GraphPad Software Inc, USA). Two-sided
P < 0.05 was considered to be statistically significant.
Additional file
Additional file 1: Detailed methods, Figure S1, Tables S1-S4.
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